FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome

Robert Q. Le, Richard Pazdur, Donna Przepiorka et al.|The Oncologist|2018

Cited by 880